Dr. Samantha Budd Haeberlein will advise the seven-person team on investments of $25 million to $100 million in life sciences companies that address unmet medical needs.
Dr. Samantha Budd Haeberlein will advise the seven-person team on investments of $25 million to $100 million in life sciences companies that address unmet medical needs.